New strategy aims to reverse heart damage in lung disease
NCT ID NCT05203510
Summary
This study is testing if starting a specific medication called treprostinil early and increasing the dose quickly can improve heart function and potentially reverse heart damage in people with pulmonary arterial hypertension (PAH). It will involve about 52 participants who are already on some standard PAH medications. The main goal is to see if this approach, which targets high blood pressure in the lungs, can make the heart's right side work better over 12 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner University Medical Center (University of Arizona)
Phoenix, Arizona, 85006, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Carilion Clinic
Roanoke, Virginia, 24014, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Community Health Network
Indianapolis, Indiana, 46219, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Georgia Clinical Research
Austell, Georgia, 30106, United States
-
Hartford Hospital
Hartford, Connecticut, 06106, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
HonorHealth John C. Lincoln Medical Center
Phoenix, Arizona, 85020, United States
-
Indiana University Health North Hospital
Indianapolis, Indiana, 46202, United States
-
Integris Baptist Medical Center
Oklahoma City, Oklahoma, 73112, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Morristown Medical Center
Morristown, New Jersey, 07960, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
Oklahoma Heart Institute
Tulsa, Oklahoma, 74104, United States
-
Prisma Health
Greenville, South Carolina, 29605, United States
-
Temple Hospital
Philadelphia, Pennsylvania, 19140, United States
-
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
USF
Tampa, Florida, 33606, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of California Davis Medical Center
Sacramento, California, 95817, United States
-
University of California San Francisco - Fresno
Fresno, California, 93701, United States
-
University of California San Francisco Pulmonary, Critical Care, Allergy and Sleep Medicine
San Francisco, California, 94143, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Rochester Medical Center
Rochester, New York, 14623, United States
Conditions
Explore the condition pages connected to this study.